The Truth about Teams
When it comes to team performance and adherence to “best practices,” what works…
Running the Biopharma Marathon
When I moved to Boston over thirty years ago, I had never even heard of the…
Rare Diseases: Shaping Biopharma’s Future from the Past
We just completed Rare Disease month. With that in mind, Sue has asked me to…
“Rare Disease” Is More Than Just a Day
You might think it odd for me to begin this month’s e-conversation with a quote…
Reading Recommendations from the High Cs
Summer is a wonderful time for catching up on our reading – whether business, pleasure, or something in between. This month, we sought out…
Are Your Assumptions Serving You Well?
Ah, June, the season of life transitions — weddings, graduations, school progression and, with the year nearly half over, a reminder to reflect on…
The Future of Biopharma Commercialization Strategy Is Now
Back in the early 2000s, I was head of commercial strategy at Millennium Pharmaceuticals in Cambridge, Massachusetts. I remember saying to then CEO,…
Biopharma Launch Planning for Emerging Companies: Four Key Challenges
Living in a parallel universe, launching a company and drug simultaneously.
Tales from the Healthcare Front Lines
Each month, you have given our team permission to communicate our views on the biopharma industry, its leadership, and overall commercialization of…
Does Boston Biotech Have a Career Navigation Problem?
For those of us who have been in the industry since pre-DRG days, and have the wisdom and experience across the industry, there are many…